Bluejay Diagnostics, Inc.

The momentum for this stock is not very good. Bluejay Diagnostics, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Bluejay Diagnostics, Inc..

News

Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Short Interest Up 523.3% in August

Zolmax Bluejay Diagnostics, Inc. (NASDAQ:BJDX - Get Free Report) was the target of a large growth in short interest in the month of August. As of August 15th, there was short interest totalling 165,800...\n more…

BJDX Stock Earnings: Bluejay Diagnostics Misses EPS for Q2 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nBJDX stock results show that Bluejay Diagnostics missed analyst estimates for earnings per share the second quarter of 2024.\nThe post...\n more…

Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Short Interest Up 1,370.0% in June

Ticker Report Bluejay Diagnostics, Inc. (NASDAQ:BJDX - Get Free Report) was the recipient of a large increase in short interest in the month of June. As of June 30th, there was short interest totalling 220,500...\n more…

Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering

Globe Newswire ACTON, Mass., June 28, 2024 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) ( Bluejay or the Company ), a medical technology company developing rapid diagnostics on its Symphony...\n more…

Bluejay Diagnostics announces pricing of $8.75M underwritten public offering

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Bluejay Diagnostics Announces Pricing of $8.75 Million Underwritten Public Offering

Globe Newswire ACTON, Mass., June 27, 2024 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) ( Bluejay or the Company ), a medical technology company developing rapid diagnostics on its Symphony...\n more…